Satellite Symposium Report
Transplantation and post-transplant immunosuppression
Year: 2009; Nr: 3; Pages: 64- 65;Safety in cytostatic compounding: the impact of automation
Year: 2009; Nr: 3; Pages: 58- 59;Clinical benefits of rivaroxaban for VTE prevention after elective hip or knee replacement surgery
Year: 2009; Nr: 34; Pages: 36- 1;Assessing biosimilars in practice: considerations for the hospital pharmacist to evaluate
Year: 2009; Nr: 3; Pages: 28- 30;Bringing the value of innovation to the patient
Year: 2009; Nr: 3; Pages: 22- 24;Last modification :18/06/2009
